Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Barket

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
European Journal of Neurology|April 30, 2025
Short-Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature ReviewAnne Zinganell, Harald Hegen, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2025
Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosisKlaus Berek, Martin Schmidauer, Gabriel Bsteh, et al.
Frontiers in Immunology|June 29, 2023
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serumKlaus Berek, Angelika Bauer, Dagmar Rudzki, et al.
Multiple Sclerosis and Related Disorders|August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC scoreGabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2026
Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trialsRoxanne Pretzsch, Sahla El Mahdaoui, Poljanka Johnson, et al.
Multiple Sclerosis and Related Disorders|April 25, 2023
Screening for osteoporosis in people with MS: A new risk scoreAnne Zinganell, Harald Hegen, Janette Walde, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
European Journal of Neurology|April 30, 2025
Short-Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature ReviewAnne Zinganell, Harald Hegen, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2025
Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosisKlaus Berek, Martin Schmidauer, Gabriel Bsteh, et al.
Frontiers in Immunology|June 29, 2023
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serumKlaus Berek, Angelika Bauer, Dagmar Rudzki, et al.
Multiple Sclerosis and Related Disorders|August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC scoreGabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2026
Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trialsRoxanne Pretzsch, Sahla El Mahdaoui, Poljanka Johnson, et al.
Multiple Sclerosis and Related Disorders|April 25, 2023
Screening for osteoporosis in people with MS: A new risk scoreAnne Zinganell, Harald Hegen, Janette Walde, et al.
Pageof 2